|
⚲
|
| Keyboard |
| Xilio Therapeutics Inc | |
|---|---|
| Ticker | XLO |
| CIK # | 0001840233 |
| CUSIP | 98422T100 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 828 Winter Street, Waltham, MA 02451 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Xilio Therapeutics Inc | 2021-02-26 | 95.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001840233] | 10-K | |
| [0001840233] | 10-Q | |
| [0001840233] | 3 | |
| [0001840233] | 4 | |
| [0001840233] | 8-K | |
| [0001840233] | D | |
| [0001840233] | SC 13D | |
| [0001840233] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Shannon James Samuel
Common Stock
|
2026-03-26 | Buy | 5,000 | $8.79 | 43,950 |
|
Gilead Sciences Inc
Prefunded Warrants (right to buy) · derivative
|
2026-02-13 | Buy | 3,739,000 | $0.53 | 1,981,670 |
|
Frankenfield Christopher James
Common Stock
|
2026-01-02 | Sell | 7,030 | $0.64 | 4,499 |
|
Brennan Kevin M
Common Stock
|
2026-01-02 | Sell | 1,826 | $0.64 | 1,169 |
|
Russo Rene
Common Stock
|
2026-01-01 | Option exercise | 44,250 | ||
|
Frankenfield Christopher James
Restricted Stock Units · derivative
|
2026-01-01 | Option exercise | 19,375 | $0.00 | |
|
Luptakova Katarina
Restricted Stock Units · derivative
|
2026-01-01 | Option exercise | 16,625 | $0.00 | |
|
Luptakova Katarina
Common Stock
|
2026-01-01 | Option exercise | 16,625 | ||
|
Russo Rene
Restricted Stock Units · derivative
|
2026-01-01 | Option exercise | 44,250 | $0.00 | |
|
Brennan Kevin M
Restricted Stock Units · derivative
|
2026-01-01 | Option exercise | 5,000 | $0.00 | |
|
Brennan Kevin M
Common Stock
|
2026-01-01 | Option exercise | 5,000 | ||
|
Frankenfield Christopher James
Common Stock
|
2026-01-01 | Option exercise | 19,375 | ||
|
Luptakova Katarina
Stock Option (right to buy) · derivative
|
2025-12-31 | Grant | 451,885 | $0.00 | |
|
Brennan Kevin M
Stock Option (right to buy) · derivative
|
2025-12-31 | Grant | 95,221 | $0.00 | |
|
Frankenfield Christopher James
Stock Option (right to buy) · derivative
|
2025-12-31 | Grant | 668,789 | $0.00 | |
|
Russo Rene
Stock Option (right to buy) · derivative
|
2025-12-31 | Grant | 1,500,258 | $0.00 | |
|
Gilead Sciences Inc
Series B Warrants (right to buy) · derivative
|
2025-11-26 | Option exercise | 13,335,000 | $0.00 | |
|
Gilead Sciences Inc
Prefunded Warrants (right to buy) · derivative
|
2025-11-26 | Option exercise | 13,335,000 | $0.75 | 10,001,250 |
|
Frankenfield Christopher James
Stock Option (right to buy) · derivative
|
2025-11-21 | Disposed to issuer | 45,000 | ||
|
Frankenfield Christopher James
Stock Option (right to buy) · derivative
|
2025-11-21 | Grant | 23,786 | ||
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 24 | 2,619,481 |
| 2025-12-31 | 37 | 39,727,815 |
| 2025-09-30 | 36 | 22,051,916 |
| 2025-06-30 | 35 | 23,770,263 |
| 2025-03-31 | 36 | 22,528,206 |
| 2024-12-31 | 36 | 25,855,355 |
| 2024-09-30 | 34 | 15,953,020 |
| 2024-06-30 | 33 | 14,509,248 |
| 2024-03-31 | 32 | 12,890,249 |
| 2023-12-31 | 35 | 16,556,871 |
| 2023-09-30 | 32 | 15,860,510 |
| 2023-06-30 | 33 | 16,002,286 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares | Prev | Page 1 | Next |